4//SEC Filing
CADENCE PHARMACEUTICALS INC 4
Accession 0001209191-09-037102
CIK 0001333248operating
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:52 PM ET
Size
9.0 KB
Accession
0001209191-09-037102
Insider Transaction Report
Form 4
Transactions
- Sale
Common stock
2009-07-20$11.00/sh−7,500$82,500→ 2,000 total - Exercise/Conversion
Common stock
2009-07-20$0.40/sh+7,500$3,000→ 9,500 total - Exercise/Conversion
Stock option (right to buy)
2009-07-20−7,500→ 72,500 totalExercise: $0.40From: 2005-02-16Exp: 2015-02-15→ common stock (7,500 underlying)
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2009.
- [F2]Not applicable to this transaction.
Documents
Issuer
CADENCE PHARMACEUTICALS INC
CIK 0001333248
Entity typeoperating
Related Parties
1- filerCIK 0001333248
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:52 PM ET
- Size
- 9.0 KB